MDCM
TECH icon

Morgan Dempsey Capital Management’s Bio-Techne TECH Stock Holding History

Morgan Dempsey Capital Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-32
Closed -$2.65K – 157
2022
Q4 		$2.65K Hold
32
– – ﹤0.01% 154
2022
Q3 		$2K Buy
+32
New +$2.77K ﹤0.01% 171

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Dempsey Capital Management's TECH Position: Q1 2023 in Review

Morgan Dempsey Capital Management sold out of Bio-Techne (TECH) in Q1 2023, closing a stake of 32 shares — an estimated $2.65K sold.

Morgan Dempsey Capital Management first reported a position in TECH in Q3 2022 and held it in 2 quarters. The position peaked at $2.65K in Q4 2022. 549 funds tracked by Wall St. Rank hold TECH as of Q1 2023.

  • Morgan Dempsey Capital Management reported no remaining Bio-Techne position as of Q1 2023 after selling out during the quarter.
  • Morgan Dempsey Capital Management sold 32 Bio-Techne shares in Q1 2023, an estimated $2.65K.
  • Morgan Dempsey Capital Management first reported a position in Bio-Techne in Q3 2022 and held it in 2 quarters.
  • Morgan Dempsey Capital Management's Bio-Techne position peaked at $2.65K in Q4 2022.
  • 549 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2023.

Based on Morgan Dempsey Capital Management's 13F filing for Q1 2023, filed 17 Apr 2023.